Dr Neoh Hui Pheng
Hospital Seberang Jaya
 Def : consequence of tightly regulated
processes that maintain blood in a fluid,
clot-free state in normal vessels while
introducing the rapid formation of a
localized hemostatic plug at the site of
vascular injury.
 Mechanism
 vasocontriction
 formation of platelet plug
 coagulation cascade
 fibrinolysis
Child with bleeding problems edited
Child with bleeding problems edited
Child with bleeding problems edited
Child with bleeding problems edited
Child with bleeding problems edited
Comparing coagulation factor and platelet defects
Coagulation factor defects Platelet disorders and von Willebrand's disease
Bruising on trunk and limbs Large bruises Small bruises
Bleeding from cuts Relatively slight Profuse
Nosebleeds Uncommon Common, frequently profuse and of long duration
Gastrointestinal bleeding Uncommon Common
Haematuria Common Rare
Haemarthrosis In severe haemophilia Very rare
Bleeding after surgery or dental extraction Up to a day's delay before bleeding occurs Immediate bleeding
Child with bleeding problems edited
 Defect in clotting mechanism
 HemophiliaA : Deficiency of FactorVIII ( 85%)
Hemophilia B : Deficiency of Factor IX ( 15%)
 70 % X linked recessive. 30 % spontaneous
mutation with no family hx.
 Rarely,bleeding symptoms may present from
birth ( Factor 8 and 9 do not cross placenta)
- Intracranial hemorrhage /prolonged oozing
from heel stick/venepuncture sites.
- Most children present with easy bruising when
crawling and walking ( ard 9-12 months)
- Hemarthrosis – characteristic.
- large joints ( ankle, knee, elbow ) – swollen and
painful
( ankle joint : often the earliest joint involved. )
 Other bleeding tendencies: Epitaxis, gum
bleeding , hematuria.
 Bleeding can be spontaneously, after trauma
, operation or dental procedures.
 Lungs/ CVS / PA : unremarkable
 FBC
 Coagulation screen : PT/ APTT
 RP / LFT
 Specific factor assay : Factor 8 or factor 9
 Von willebrand screen even ifAPTT normal .
Others :
- Infective screen ( at diagnosis and yearly) :
Hep B/ Hep C /HIV
- Platelet aggregation if highly suspicious of
platelet defect.
Classification Clinical manifestation
Severe
(<1% of normal)
•Manifest in infancy when child reaches toddler stage
• Spontaneous bleeding – in muscles or joints (haemarthroses)
• Excessive bleeding after minor trauma, postoperatively, or
after intramuscular childhood vaccinations
Moderate
( 1-5% of normal)
•Manifest after 2 years of life
• Moderate trauma causes bleeding episodes
• Occasionally spontaneous bleeding occurs
Mild
( >5 % - < 40% of
normal)
•Often diagnosed in teenagers and adults
• Significant trauma/surgery or dental procedures to induce
bleeding
• No spontaneous bleeding
 First Aid ( PRICE) : Pressure, Rest, Ice,
Elevation
 FactorVIII /IX replacement
Infuse factor 8 by slow IV push at the rate not exceeding 100U/
min in young children.
 FFP and cryoprecipitate should not be used as there
is higher risk of viral transmission.
Type of bleed FactorVIII dose Factor IX dose
Hemarthrosis 20U/kg 40 U /kg
Soft tissue or
muscle bleeds
30-40U/kg 60-80U /kg
Intracranial
hemorrhage or
Surgery
50U /kg 100 U /kg
Calculate the required dose:
- FactorVIII : ( % rise reqd) x ( wt in kg) x 0.5
- Factor IX : (% rise reqd) x ( wt in kg) x 1.4
Type of bleed % rise required duration
Haemarthroses 30-40% 2-3 days
Soft tissue /Muscle
bleed
( Risk of
compression/comp
artment syndrome)
40-50% 4-5 days
Intracranial bleed
/operation
100% 7-10days
 Analgesic often not required ( as there is
rapid pain relief after missing factor
concentrate is infused)
- AVOID I.M injection
- Don’t use Aspirin/NSAIDs – affect platelet fx
- Acetaminophen with or without opioids can
provide adequate pain control
 Dental care is required as dental caries are a
regular source of bleeding.
 In severe cases, dental clearance with factor
replacement will be required.
 Medic alert bracelet
 Register with hemophilia society.
1) Joint destruction : Recurrent hemarthrosis
into the same joint  osteoarthritis and joint
deformity.
 Preventable by prompt and adequate factor 8
replacement.
2) Infection : Hep B/Hep C and HIV
- All hemophiliacs must be immunised with
Hep B
3) Inhibitors: Antibodies directed against the
exogeneous FactorVIII and IX neutralising the clotting
activity.
Can develop at ANY age, but usually 10-20 exposure
days.
Suspected when there is lack of response to
replacement therapy instead of higher doses.
 2 agents – “bypassing” the deficient clotting factor :
i) Recombinant activated FactorVII ( rfVII or
Novoseven)
ii) FEIBA ( Factor Eight Inhibitor Bypass Activity)
 Immune tolerance induction
 Refer to hematologist in specialised centres.
Child with bleeding problems edited
Child with bleeding problems edited
 neonatal alloimmune thrombocytopenia
- Thrombocytopenia in < 6 months
 Sepsis and infections ( eg HIV )
 Drug induced thrombocytopenia
 Hematological Malignancy
-eg : Acute leukemia
 Congenital marrow failure syndromes
-eg : Fanconi anemia , thrombocytopenia with absent radius
 Autoimmune disorders
- Eg : SLE , Evan syndrome
 Primary immunodeficiency syndromes
-Wiskott-aldrich syndrome
 Immune thrombocytopenic purpura
 Isolated thrombocytopenia with NORMAL blood
counts in a patient, with no clinically apparent
alternative cause of thrombocytopenia .
 In children, ITP is an acute but self limiting that
resolves spontaneously.
Autoantibodies bind to platelet membrane antigen
Increased platelet destruction
Subtypes : 1) Acute ITP
2) Chronic ITP
 Usually acute onset.
 Majority will have h/o viral infection in the
preceding 2-4 weeks.
 Can be present as mild cutaneous bleed like
petechiae , to mucosal bleeds like gum
bleeding or epitaxis , to life threathening
bleeds like Intracranial hemorrhage.
 Based on history, examination and investigation.
 Physical examination : Absence of
hepatosplenomegaly or lymphadenopathy.
 FBC : Isolated low platelet, normal Hb andTWBC
 FBP : Normal, apart from reduced larger
platelet, no abnormal cells.
 Coagulation profile : prolonged BT, normal PT
and APTT.
Usually not require BMA, unless child present with
Atypical features ( eg : Organomegaly, significant
lymphadenopathy, abnormal blood counts or suspicious
FBP. )
 Before starting steroid therapy ( to avoid partially
inducing an undiagnosed acute leukemia)
 If there is failure to respond to Immunoglobulin
therapy
 When there is persistent thrombocytopenia more
than 6 months.
 Thrombocytopenia recurs after initial response to
treatment.
 Antinuclear factor and DNA antibodies
 Coomb’s test
 CMV serology ( < 1 yr old )
 Coagulation profile ( suspected NAI and
inherited bleeding disorder)
 HIV testing for those at risk ( eg parents RVD
+ or IVDU )
 Immunoglobulin factor for those with
recurrent infection
 Most children remit spontaneously
- 70% achieve platelet count > 50x 109
/L by the end of 3rd
week.
 Careful observation with monitoring of platelet count ,
without specific treatment is appropriate for patient with :
- Platelet count > 20x 109
/L without bleeding
- Platelet count > 30x 109
/L with only cutaneous purpura
- repeat FBC within 7-10 days to ensure there is no evidence
of serious evolving marrow condition.
 Advise precautions with physical activities , avoidance of
contact sports and seeking immediate medical attention if
bleeding occurs should be advised.
 Hospitalise the child if
- Severe life threathening bleding eg ICH
regardless of platelet count
- Platelet count < 20x 109
/L with evidence of
bleeding
- Platelet count < 20x 109
/L without bleeding but
inaccessible to health care.
- Parents request due to lack of confidence in home
care.
Treatment indicated if
- Life threathening bleeding like ICH
- Platelet count < 20x 109
/L with mucosal bleeding
- Platelet count < 10x 109
/L with any bleeding
Choices of treatment:
i) Oral prednisolone 2mg/kg/day for 14 days
then taper off
ii) Oral prednisolone 4mg/kg/day for 4 days
iii) IVIG 0.8mg/kg/dose for a single dose.
Note that the above mentioned regimes do not help to
reduce bleeding complications or mortality or
influence progression to chronic ITP.
S/E of IVIG ( 15-75%) :
- fever, flushing, headache, nausea, aseptic meningitis,
transmission of Hep C ( older preparation )
 Steroid should not be continued if there is no
response or if there is a rapid relapse after withdrawal.
 Treatment should not be directed at increasing the
platelet count above a preset level but rather on the
clinical status of the patient.
 Persistent thrombocytopenia after 6 months
of onset ( in 20% )
 Wide spectrum of manifestation:
- Mild asymptomatic low platelet count ->
intermittent relapsing symptomatic
thrombocytopenia -> rare stubborn and
persistent symptomatic and hemorrhagic
disease.
Feature Acute ITP Chronic ITP
Peak age Children (2-6 yrs) Adults (20-40 yrs)
Female:male 1:1 3:1
Antecedent Infection Common Rare
Onset of symptoms Abrupt Insidious
Platelet count at
presentation
<20 000 <50 000
Duration 2-6 weeks Long term
Spontaneous remission Common Uncommon
 Try to give enough time for the disease to remit
spontaneously.
 EXCLUDE other causes of thrombocytopenia.
 Asymptomatic child – Observe and conservative +
precaution in physical activity
 Symptomatic- short course of treatment like acute
ITP
 Counselling to parents- natural history of disease and
detecting symptoms and complications.
 Parents should be confident in taking care of child
with persistent low platelet count at home.
 Must know when and how to seek early medical
attention.
 For child with persistent bleeding.
 MUST d/w paediatric hematologist before
initiating.
 Pulses of steroid :
- Oral dexamethasone 1mg/kg given on 4
consecutive days every 4 weeks for 4 months.
 Intermittent anti-RhD Immunoglobulin
treatment for Rh +ve : 45-50mcg/kg – May
cause drop in Hb level.
 Splenectomy is rarely indicated.
Platelet
count
PT APTT Bleedin
g time
Thrombin
time
Additional
test
Hemophilia
A
N N Prolonged N Factor 8 low
Hemophilia
B
N N Prolonged N Factor 9 low
Von
Willebrand’
s disease
N N Prolonged
or
Normal
N VWF /
Factor 8 low
- Impaired
ristocetin
impaired
platelet
aggregation
Liver
disease
Low Prolonged prolonged N
(Rarely
prolonged
)
DIC Low Prolonged prolonged Grossly
prolonged
Oral N Grossly Prolonged N
 April 2013
 10 yrs old , Chinese , boy, BW : 30kg
p/w :
1) pain, swelling and reduced movement for both
elbows X 2/7
2) Bruises over bilateral knee
Denies history of recent contact sports.
Denies history of trauma
Denies history of fall.
No other bleeding tendency like epitaxis, gum bleeding,
hemetemesis, hemoptysis, hematuria, malena,
petechiae or bruises at other body part.
 He has had multiple previous admissions
since young for joint swellings or soft tissue
injury like calf swelling and bruises.
 Child was previously followed up in Hospital
SultanahAminah since 1 yr old of age.
 Blood investigation during 1 yr old:
- PT 11.9
- APTT 106.6
- FactorVIII <1.0%
- VonWillebrand factor 103.1%
Child with bleeding problems edited
 He was diagnosed with Hemophilia A since 1 yr old.
 In 2012, he was referred to HSJ for follow up due to
logistic reason .
 May 2012 : right thigh swelling after a fall
- FactorVIII 750U ( 30U/kg ) x 3 doses
 August 2012:right elbow swelling and bruises after
falling down in basketball court.
- FactorVIII 750U x 15 doses
 September 2012 : bilateral knee bruises after playing
with a friend.
- FactorVIII 750 U x 7 doses
 November 2012: Swelling over elbow . Admitted to
HSAH in SP. FactorVIII given, child was not admitted.
 Development history: standard 4 student
with average performance. ( frequent
absence from school due to frequent
admissions)
 Family & Social history:
Father is single parent. Mother is cambodian,
was told to be carrier of hemophilia. Parents
already divorced. He is the only son.
 o/e :
Alert, pink , active and comfortable.
Not dyspneic, not tachypneic.
Good perfusion , good pulse volume, CRT < 2 secs.
No petechiae over body. No gum bleeding/nose
bleeding.
Lungs : A/E equal, clear
CVS : DRNM
PA : soft, not distended, no liver / spleen palpable.
Local findings :both elbows slightly swollen and warm
on touch. Restricted ROM : 75-135 degrees bilaterally.
Bruises over both knees. However, bilateral knee has full
ROM.
 Ix :
- FBC : Hb 12.8 ,TWC 8.4 , Plt 414
- PT 12.6, APTT 85.5 , INR 1.0
Management:
- Given FactorVIII 750 U BD ( 25mg/kg/dose) for
2 days, followed by 750U OD for 3 days. A
total of 7 doses given.
- Subsequently, child had full ROM in right
elbow, however, his left elbow still slightly
restricted to 15-145 degrees.
 TCA stat if hemarthrosis/ soft tissue bleeding
/ bleeding tendency.
 Advise child not to take part in contact
sports.
Child with bleeding problems edited

More Related Content

PPTX
DEEP VEIN THROMBOSIS
PPTX
Heamophilia
PPTX
How to approach a child with bleeding disorder
PPTX
Psoriatic arthritis
PPTX
Thalassemia
PPT
Fluid And Electrolyte Emergencies In Critically Ill Children
PPTX
Constipation in children
PPTX
Bleeding and clotting disorders in children
DEEP VEIN THROMBOSIS
Heamophilia
How to approach a child with bleeding disorder
Psoriatic arthritis
Thalassemia
Fluid And Electrolyte Emergencies In Critically Ill Children
Constipation in children
Bleeding and clotting disorders in children

What's hot (20)

PDF
Bleeding disorders in children 2021
PPTX
Anuupam ppt for bleeding child
PPTX
Aproach to bleeding disorder in Pediatrics
PPTX
Hemophilia
PPTX
Approach to a bleeding child
PPTX
Approach to bleeding disorder (coagulation defects) in children
PDF
Approach to bleeding child
PPTX
Hemophilia presentation
PPT
20100603 acute glomerulonephritis
PPTX
Paediatric Hemophilia
PPTX
Hemophilia
PPTX
Approach to bleeding disorder
PPTX
Approch to child With bleeding
PPTX
Blood transfusion in pediatrics part1
PPT
Presantation on bleeding disorder in pediatric patients
PPT
Hemophilia (a) - Pediatrics
PPTX
Approach to a child with bleeding for UGs
PPTX
Idiopathic Thrombocytopenic Purpura
PPT
19 Acute Glomerulonephritis
PPTX
Pancytopenia in pediatrcs
Bleeding disorders in children 2021
Anuupam ppt for bleeding child
Aproach to bleeding disorder in Pediatrics
Hemophilia
Approach to a bleeding child
Approach to bleeding disorder (coagulation defects) in children
Approach to bleeding child
Hemophilia presentation
20100603 acute glomerulonephritis
Paediatric Hemophilia
Hemophilia
Approach to bleeding disorder
Approch to child With bleeding
Blood transfusion in pediatrics part1
Presantation on bleeding disorder in pediatric patients
Hemophilia (a) - Pediatrics
Approach to a child with bleeding for UGs
Idiopathic Thrombocytopenic Purpura
19 Acute Glomerulonephritis
Pancytopenia in pediatrcs
Ad

Viewers also liked (9)

PPTX
Approach to diagnosis of bleeding disorders
PDF
Rational approach to evaluate a bleeding patient 2014
PPTX
Bleeding disorder von Willebrand disease Type III
PPTX
Bleeding neonate / child
PPTX
ACUTE GI BLEEDING
PPTX
Bleeding disorder
PPTX
Hemophilia
PPT
Blood #5, Platelets & Hemostasis - Physiology
PPT
CME: Bleeding disorders - Diagnostic Approach
Approach to diagnosis of bleeding disorders
Rational approach to evaluate a bleeding patient 2014
Bleeding disorder von Willebrand disease Type III
Bleeding neonate / child
ACUTE GI BLEEDING
Bleeding disorder
Hemophilia
Blood #5, Platelets & Hemostasis - Physiology
CME: Bleeding disorders - Diagnostic Approach
Ad

Similar to Child with bleeding problems edited (20)

PPTX
Immune thrombocytopenic purpura(ITP) .pptx
PPTX
Hemorragics.pptx
PPTX
Hemophilia and ITP
PPT
Medicine 5th year, 10th lecture (Dr. Sabir)
PPTX
Blood disorders (3) copy.pptx types ad mangment
PPTX
Idiopathicthrombocytopenicpurpura 151213171711
PPT
23 Ppt Itp
DOC
Idiopathic Thrombocytopenic Purpura
PPTX
Idiopathic thrombocytopenc purpra # kiran sadik
PPTX
Idiopathic thrombocytopenc purpra # kiran sadik
PPTX
Idiopathic thrombocytopenic purpura.pptx
PPT
ITP.ppt
PPTX
Immune Thrombocytopenia (ITP)
PPTX
HEMOPHILIA-introduction , diagnosis, clinical features, management
PPTX
Bleeding & Coagulation disorders case and evaluationA
PPT
thrombo done1.ppt
PPT
thrombo done2.ppt
PPTX
Platelet disoders
PPTX
5. bleeding disorder
Immune thrombocytopenic purpura(ITP) .pptx
Hemorragics.pptx
Hemophilia and ITP
Medicine 5th year, 10th lecture (Dr. Sabir)
Blood disorders (3) copy.pptx types ad mangment
Idiopathicthrombocytopenicpurpura 151213171711
23 Ppt Itp
Idiopathic Thrombocytopenic Purpura
Idiopathic thrombocytopenc purpra # kiran sadik
Idiopathic thrombocytopenc purpra # kiran sadik
Idiopathic thrombocytopenic purpura.pptx
ITP.ppt
Immune Thrombocytopenia (ITP)
HEMOPHILIA-introduction , diagnosis, clinical features, management
Bleeding & Coagulation disorders case and evaluationA
thrombo done1.ppt
thrombo done2.ppt
Platelet disoders
5. bleeding disorder

Recently uploaded (20)

PPTX
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study
PDF
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
PDF
Calcified coronary lesions management tips and tricks
PPTX
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
PDF
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
PDF
OSCE SERIES ( Questions & Answers ) - Set 5.pdf
PDF
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
PPTX
y4d nutrition and diet in pregnancy and postpartum
PPTX
Acute Coronary Syndrome for Cardiology Conference
PDF
Lecture 8- Cornea and Sclera .pdf 5tg year
PPTX
thio and propofol mechanism and uses.pptx
PPTX
Wheat allergies and Disease in gastroenterology
PPTX
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
PDF
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
PPT
nephrology MRCP - Member of Royal College of Physicians ppt
PDF
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
PDF
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
PDF
OSCE Series ( Questions & Answers ) - Set 6.pdf
PPTX
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
PPTX
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
Calcified coronary lesions management tips and tricks
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
OSCE SERIES ( Questions & Answers ) - Set 5.pdf
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
y4d nutrition and diet in pregnancy and postpartum
Acute Coronary Syndrome for Cardiology Conference
Lecture 8- Cornea and Sclera .pdf 5tg year
thio and propofol mechanism and uses.pptx
Wheat allergies and Disease in gastroenterology
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
nephrology MRCP - Member of Royal College of Physicians ppt
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
OSCE Series ( Questions & Answers ) - Set 6.pdf
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...

Child with bleeding problems edited

  • 1. Dr Neoh Hui Pheng Hospital Seberang Jaya
  • 2.  Def : consequence of tightly regulated processes that maintain blood in a fluid, clot-free state in normal vessels while introducing the rapid formation of a localized hemostatic plug at the site of vascular injury.  Mechanism  vasocontriction  formation of platelet plug  coagulation cascade  fibrinolysis
  • 8. Comparing coagulation factor and platelet defects Coagulation factor defects Platelet disorders and von Willebrand's disease Bruising on trunk and limbs Large bruises Small bruises Bleeding from cuts Relatively slight Profuse Nosebleeds Uncommon Common, frequently profuse and of long duration Gastrointestinal bleeding Uncommon Common Haematuria Common Rare Haemarthrosis In severe haemophilia Very rare Bleeding after surgery or dental extraction Up to a day's delay before bleeding occurs Immediate bleeding
  • 10.  Defect in clotting mechanism  HemophiliaA : Deficiency of FactorVIII ( 85%) Hemophilia B : Deficiency of Factor IX ( 15%)  70 % X linked recessive. 30 % spontaneous mutation with no family hx.
  • 11.  Rarely,bleeding symptoms may present from birth ( Factor 8 and 9 do not cross placenta) - Intracranial hemorrhage /prolonged oozing from heel stick/venepuncture sites. - Most children present with easy bruising when crawling and walking ( ard 9-12 months) - Hemarthrosis – characteristic. - large joints ( ankle, knee, elbow ) – swollen and painful ( ankle joint : often the earliest joint involved. )
  • 12.  Other bleeding tendencies: Epitaxis, gum bleeding , hematuria.  Bleeding can be spontaneously, after trauma , operation or dental procedures.  Lungs/ CVS / PA : unremarkable
  • 13.  FBC  Coagulation screen : PT/ APTT  RP / LFT  Specific factor assay : Factor 8 or factor 9  Von willebrand screen even ifAPTT normal . Others : - Infective screen ( at diagnosis and yearly) : Hep B/ Hep C /HIV - Platelet aggregation if highly suspicious of platelet defect.
  • 14. Classification Clinical manifestation Severe (<1% of normal) •Manifest in infancy when child reaches toddler stage • Spontaneous bleeding – in muscles or joints (haemarthroses) • Excessive bleeding after minor trauma, postoperatively, or after intramuscular childhood vaccinations Moderate ( 1-5% of normal) •Manifest after 2 years of life • Moderate trauma causes bleeding episodes • Occasionally spontaneous bleeding occurs Mild ( >5 % - < 40% of normal) •Often diagnosed in teenagers and adults • Significant trauma/surgery or dental procedures to induce bleeding • No spontaneous bleeding
  • 15.  First Aid ( PRICE) : Pressure, Rest, Ice, Elevation  FactorVIII /IX replacement Infuse factor 8 by slow IV push at the rate not exceeding 100U/ min in young children.  FFP and cryoprecipitate should not be used as there is higher risk of viral transmission.
  • 16. Type of bleed FactorVIII dose Factor IX dose Hemarthrosis 20U/kg 40 U /kg Soft tissue or muscle bleeds 30-40U/kg 60-80U /kg Intracranial hemorrhage or Surgery 50U /kg 100 U /kg
  • 17. Calculate the required dose: - FactorVIII : ( % rise reqd) x ( wt in kg) x 0.5 - Factor IX : (% rise reqd) x ( wt in kg) x 1.4 Type of bleed % rise required duration Haemarthroses 30-40% 2-3 days Soft tissue /Muscle bleed ( Risk of compression/comp artment syndrome) 40-50% 4-5 days Intracranial bleed /operation 100% 7-10days
  • 18.  Analgesic often not required ( as there is rapid pain relief after missing factor concentrate is infused) - AVOID I.M injection - Don’t use Aspirin/NSAIDs – affect platelet fx - Acetaminophen with or without opioids can provide adequate pain control
  • 19.  Dental care is required as dental caries are a regular source of bleeding.  In severe cases, dental clearance with factor replacement will be required.  Medic alert bracelet  Register with hemophilia society.
  • 20. 1) Joint destruction : Recurrent hemarthrosis into the same joint  osteoarthritis and joint deformity.  Preventable by prompt and adequate factor 8 replacement. 2) Infection : Hep B/Hep C and HIV - All hemophiliacs must be immunised with Hep B
  • 21. 3) Inhibitors: Antibodies directed against the exogeneous FactorVIII and IX neutralising the clotting activity. Can develop at ANY age, but usually 10-20 exposure days. Suspected when there is lack of response to replacement therapy instead of higher doses.  2 agents – “bypassing” the deficient clotting factor : i) Recombinant activated FactorVII ( rfVII or Novoseven) ii) FEIBA ( Factor Eight Inhibitor Bypass Activity)  Immune tolerance induction  Refer to hematologist in specialised centres.
  • 24.  neonatal alloimmune thrombocytopenia - Thrombocytopenia in < 6 months  Sepsis and infections ( eg HIV )  Drug induced thrombocytopenia  Hematological Malignancy -eg : Acute leukemia  Congenital marrow failure syndromes -eg : Fanconi anemia , thrombocytopenia with absent radius  Autoimmune disorders - Eg : SLE , Evan syndrome  Primary immunodeficiency syndromes -Wiskott-aldrich syndrome  Immune thrombocytopenic purpura
  • 25.  Isolated thrombocytopenia with NORMAL blood counts in a patient, with no clinically apparent alternative cause of thrombocytopenia .  In children, ITP is an acute but self limiting that resolves spontaneously. Autoantibodies bind to platelet membrane antigen Increased platelet destruction Subtypes : 1) Acute ITP 2) Chronic ITP
  • 26.  Usually acute onset.  Majority will have h/o viral infection in the preceding 2-4 weeks.  Can be present as mild cutaneous bleed like petechiae , to mucosal bleeds like gum bleeding or epitaxis , to life threathening bleeds like Intracranial hemorrhage.
  • 27.  Based on history, examination and investigation.  Physical examination : Absence of hepatosplenomegaly or lymphadenopathy.  FBC : Isolated low platelet, normal Hb andTWBC  FBP : Normal, apart from reduced larger platelet, no abnormal cells.  Coagulation profile : prolonged BT, normal PT and APTT.
  • 28. Usually not require BMA, unless child present with Atypical features ( eg : Organomegaly, significant lymphadenopathy, abnormal blood counts or suspicious FBP. )  Before starting steroid therapy ( to avoid partially inducing an undiagnosed acute leukemia)  If there is failure to respond to Immunoglobulin therapy  When there is persistent thrombocytopenia more than 6 months.  Thrombocytopenia recurs after initial response to treatment.
  • 29.  Antinuclear factor and DNA antibodies  Coomb’s test  CMV serology ( < 1 yr old )  Coagulation profile ( suspected NAI and inherited bleeding disorder)  HIV testing for those at risk ( eg parents RVD + or IVDU )  Immunoglobulin factor for those with recurrent infection
  • 30.  Most children remit spontaneously - 70% achieve platelet count > 50x 109 /L by the end of 3rd week.  Careful observation with monitoring of platelet count , without specific treatment is appropriate for patient with : - Platelet count > 20x 109 /L without bleeding - Platelet count > 30x 109 /L with only cutaneous purpura - repeat FBC within 7-10 days to ensure there is no evidence of serious evolving marrow condition.  Advise precautions with physical activities , avoidance of contact sports and seeking immediate medical attention if bleeding occurs should be advised.
  • 31.  Hospitalise the child if - Severe life threathening bleding eg ICH regardless of platelet count - Platelet count < 20x 109 /L with evidence of bleeding - Platelet count < 20x 109 /L without bleeding but inaccessible to health care. - Parents request due to lack of confidence in home care.
  • 32. Treatment indicated if - Life threathening bleeding like ICH - Platelet count < 20x 109 /L with mucosal bleeding - Platelet count < 10x 109 /L with any bleeding Choices of treatment: i) Oral prednisolone 2mg/kg/day for 14 days then taper off ii) Oral prednisolone 4mg/kg/day for 4 days iii) IVIG 0.8mg/kg/dose for a single dose.
  • 33. Note that the above mentioned regimes do not help to reduce bleeding complications or mortality or influence progression to chronic ITP. S/E of IVIG ( 15-75%) : - fever, flushing, headache, nausea, aseptic meningitis, transmission of Hep C ( older preparation )  Steroid should not be continued if there is no response or if there is a rapid relapse after withdrawal.  Treatment should not be directed at increasing the platelet count above a preset level but rather on the clinical status of the patient.
  • 34.  Persistent thrombocytopenia after 6 months of onset ( in 20% )  Wide spectrum of manifestation: - Mild asymptomatic low platelet count -> intermittent relapsing symptomatic thrombocytopenia -> rare stubborn and persistent symptomatic and hemorrhagic disease.
  • 35. Feature Acute ITP Chronic ITP Peak age Children (2-6 yrs) Adults (20-40 yrs) Female:male 1:1 3:1 Antecedent Infection Common Rare Onset of symptoms Abrupt Insidious Platelet count at presentation <20 000 <50 000 Duration 2-6 weeks Long term Spontaneous remission Common Uncommon
  • 36.  Try to give enough time for the disease to remit spontaneously.  EXCLUDE other causes of thrombocytopenia.  Asymptomatic child – Observe and conservative + precaution in physical activity  Symptomatic- short course of treatment like acute ITP  Counselling to parents- natural history of disease and detecting symptoms and complications.  Parents should be confident in taking care of child with persistent low platelet count at home.  Must know when and how to seek early medical attention.
  • 37.  For child with persistent bleeding.  MUST d/w paediatric hematologist before initiating.  Pulses of steroid : - Oral dexamethasone 1mg/kg given on 4 consecutive days every 4 weeks for 4 months.  Intermittent anti-RhD Immunoglobulin treatment for Rh +ve : 45-50mcg/kg – May cause drop in Hb level.  Splenectomy is rarely indicated.
  • 38. Platelet count PT APTT Bleedin g time Thrombin time Additional test Hemophilia A N N Prolonged N Factor 8 low Hemophilia B N N Prolonged N Factor 9 low Von Willebrand’ s disease N N Prolonged or Normal N VWF / Factor 8 low - Impaired ristocetin impaired platelet aggregation Liver disease Low Prolonged prolonged N (Rarely prolonged ) DIC Low Prolonged prolonged Grossly prolonged Oral N Grossly Prolonged N
  • 39.  April 2013  10 yrs old , Chinese , boy, BW : 30kg p/w : 1) pain, swelling and reduced movement for both elbows X 2/7 2) Bruises over bilateral knee Denies history of recent contact sports. Denies history of trauma Denies history of fall. No other bleeding tendency like epitaxis, gum bleeding, hemetemesis, hemoptysis, hematuria, malena, petechiae or bruises at other body part.
  • 40.  He has had multiple previous admissions since young for joint swellings or soft tissue injury like calf swelling and bruises.  Child was previously followed up in Hospital SultanahAminah since 1 yr old of age.  Blood investigation during 1 yr old: - PT 11.9 - APTT 106.6 - FactorVIII <1.0% - VonWillebrand factor 103.1%
  • 42.  He was diagnosed with Hemophilia A since 1 yr old.  In 2012, he was referred to HSJ for follow up due to logistic reason .  May 2012 : right thigh swelling after a fall - FactorVIII 750U ( 30U/kg ) x 3 doses  August 2012:right elbow swelling and bruises after falling down in basketball court. - FactorVIII 750U x 15 doses  September 2012 : bilateral knee bruises after playing with a friend. - FactorVIII 750 U x 7 doses  November 2012: Swelling over elbow . Admitted to HSAH in SP. FactorVIII given, child was not admitted.
  • 43.  Development history: standard 4 student with average performance. ( frequent absence from school due to frequent admissions)  Family & Social history: Father is single parent. Mother is cambodian, was told to be carrier of hemophilia. Parents already divorced. He is the only son.
  • 44.  o/e : Alert, pink , active and comfortable. Not dyspneic, not tachypneic. Good perfusion , good pulse volume, CRT < 2 secs. No petechiae over body. No gum bleeding/nose bleeding. Lungs : A/E equal, clear CVS : DRNM PA : soft, not distended, no liver / spleen palpable. Local findings :both elbows slightly swollen and warm on touch. Restricted ROM : 75-135 degrees bilaterally. Bruises over both knees. However, bilateral knee has full ROM.
  • 45.  Ix : - FBC : Hb 12.8 ,TWC 8.4 , Plt 414 - PT 12.6, APTT 85.5 , INR 1.0 Management: - Given FactorVIII 750 U BD ( 25mg/kg/dose) for 2 days, followed by 750U OD for 3 days. A total of 7 doses given. - Subsequently, child had full ROM in right elbow, however, his left elbow still slightly restricted to 15-145 degrees.
  • 46.  TCA stat if hemarthrosis/ soft tissue bleeding / bleeding tendency.  Advise child not to take part in contact sports.